News Quantified

ANAB – anaptysbio, inc. (US:NASDAQ)

Hidradenitis Suppurativa Pipeline Analysis Report 2024: Featuring 24+ Companies and 24+ Pipeline Drugs Including Vilobelimab (InflaRx), Secukinumab (Novartis), Avacopan (Chemo Centryx), Imsidolimab (AnaptysBio) [Yahoo! Finance]

5/1

06:19 am

anab

Medium

AnaptysBio (ANAB) Soars 14.3%: Is Further Upside Left in the Stock? [Yahoo! Finance]

Actym Therapeutics Appoints Thomas Smart as CEO [Yahoo! Finance]

Actym Therapeutics Appoints Thomas Smart as CEO

AnaptysBio, Inc. (NASDAQ: ANAB) had its "outperform" rating re-affirmed by analysts at Leerink Partnrs.

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}